Honorary Professor

Janet Hardy

Email: 

Availability

Honorary Professor Janet Hardy is:
Available for supervision

Fields of research

Health Sciences Oncology and carcinogenesis Pharmacology and pharmaceutical sciences

Qualifications

  • Bachelor of Medicine Surgery, The University of Auckland
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Search Professor Janet Hardy’s works on UQ eSpace

264 works between 1987 and 2026
All (264) Book (1) Journal Article (209) Other Outputs (1) Conference Publication (26) Book Chapter (27)

261 - 264 of 264 works

1989

Conference Publication

Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women

Lonning, PE, Dowsett, M, Jacobs, S, Schem, B, Hardy, J and Powles, TJ (1989). Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women. 9th International Symp of the Journal of Steroid Biochemistry : Recent Advances in Steroid Biochemistry, Las Palmas Gran Canaria Spain, May 28-31, 1989. doi: 10.1016/0022-4731(89)90143-X

Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women

1988

Journal Article

Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921)

Hardy, JR, Harvey, VJ, Paxton, JW, Evans, P, Smith, S, Grove, W, Grillolopez, AJ and Baguley, BC (1988). Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921). Cancer Research, 48 (22), 6593-6596.

Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921)

1988

Journal Article

The Clinical Pharmacokinetics of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulfonylamino)phenylamino]-4-Acridinecarboxamide (ci-921) in a Phase-1 Trial

Paxton, JW, Hardy, JR, Evans, PC, Harvey, VJ and Baguley, BC (1988). The Clinical Pharmacokinetics of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulfonylamino)phenylamino]-4-Acridinecarboxamide (ci-921) in a Phase-1 Trial. Cancer Chemotherapy and Pharmacology, 22 (3), 235-240. doi: 10.1007/BF00273417

The Clinical Pharmacokinetics of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulfonylamino)phenylamino]-4-Acridinecarboxamide (ci-921) in a Phase-1 Trial

1987

Journal Article

The Treatment of Advanced Recurrent Carcinoma of the Uterine Cervix with Platinum Based Cytotoxic Chemotherapy

Hardy, JR, Maclean, GD, Foote, GA and Harvey, VJ (1987). The Treatment of Advanced Recurrent Carcinoma of the Uterine Cervix with Platinum Based Cytotoxic Chemotherapy. Australian & New Zealand Journal of Obstetrics & Gynaecology, 27 (2), 146-149. doi: 10.1111/j.1479-828X.1987.tb00967.x

The Treatment of Advanced Recurrent Carcinoma of the Uterine Cervix with Platinum Based Cytotoxic Chemotherapy

Current funding

  • 2021 - 2027
    Medicinal Cannabis (MedCan 3) - randomised, multicentre, double blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer
    NHMRC MRFF EPCDR Medicinal Cannabis
    Open grant

Past funding

  • 2018 - 2023
    Medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer
    NHMRC MRFF - Lifting Clinical Trials Registries Capacity
    Open grant
  • 2017 - 2020
    Talking about death: A study into palliative care communication
    Mater Misericordiae Ltd
    Open grant
  • 2010 - 2016
    A randomised controlled trial of aetiology based antiemetic guidelines for reducing nausea in advanced cancer patients (NHMRC Project Grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2010 - 2012
    n-of-1 trials of pilocarpine vs placebo for dry mouth in palliative care patients
    Cancer Council Queensland
    Open grant
  • 2009 - 2012
    Using n-of 1 trials to determine the effectiveness of paracetamol in advanced cancer patients on opioids
    NHMRC Palliative Care Research Program
    Open grant
  • 2008 - 2012
    Using single patient trials to determine the effectiveness of psychostimulants in end stage fatigue in cancer patients.
    NHMRC Palliative Care Research Program
    Open grant

Availability

Honorary Professor Janet Hardy is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Enquiries

For media enquiries about Honorary Professor Janet Hardy's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au